This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.
HB1796-FN: allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.
s findings and recommendations, within 180 days of the effective date of this chapter. 4 New Subparagraph; Application of Receipts; Therapeutic Psilocybin Treatment Fund. Amend RSA 6:12, I(b) by inserting after subparagraph (410) the following new subparagraph: (411) Moneys deposited in the therapeutic psilocybin treatment fund as established in RSA 126-XX:11. 5 Effective Date. This act shall ta
Related law links
RSA references in this bill
- 126-X · reference
- 318-B · reference
- 326-B · reference
- 328-D · reference
- 329 · reference
- 329-B · reference
- 330-A · reference
- 541-A · reference
- 6:12 · amend
RSAs mentioned by this document
- RSA 6 · STATE TREASURER AND STATE ACCOUNTS
- RSA 126-X · USE OF CANNABIS FOR THERAPEUTIC PURPOSES
- RSA 318-B · CONTROLLED DRUG ACT
- RSA 326-B · NURSE PRACTICE ACT
- RSA 328-D · PHYSICIAN ASSOCIATES
- RSA 329 · PHYSICIANS AND SURGEONS
- RSA 329-B · PSYCHOLOGISTS
- RSA 330-A · MENTAL HEALTH PRACTICE
- RSA 541-A · ADMINISTRATIVE PROCEDURE ACT
- RSA 6:12 · Application of Receipts